Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2008
Isolation of drug-resistant mutant HIV variants using tissue culture drug selectionMaureen Oliveira, Bluma G Brenner, Mark A WainbergAntimicrobial Agents and Chemotherapy|January 25, 2003
Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutationYudong Quan, Bluma G Brenner, Maureen Oliveira, et al.AIDS (London, England)|April 7, 2007
Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutationsFernando A Frankel, Cédric F Invernizzi, Maureen Oliveira, et al.Journal of Virology|February 6, 2015
Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutionsKaitlin Anstett, Thibault Mesplede, Maureen Oliveira, et al.Journal of Virology|August 28, 2015
The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug ResistanceJiaming Liang, Thibault Mesplède, Maureen Oliveira, et al.Antimicrobial Agents and Chemotherapy|November 23, 2006
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitorsMichel Ntemgwa, Bluma G Brenner, Maureen Oliveira, et al.AIDS (London, England)|January 28, 2014
Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitorsMaureen Oliveira, Thibault Mesplède, Peter K Quashie, et al.Journal of the International AIDS Society|November 14, 2014
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compoundMark Wainberg, Kaitlin Anstett, Thibault Mesplede, et al.Journal of Virology|August 7, 2002
The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virusJames B Whitney, Maureen Oliveira, Mervi Detorio, et al.The Journal of Antimicrobial Chemotherapy|September 21, 2010
Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme functionHong-Tao Xu, Maureen Oliveira, Yudong Quan, et al.Pageof 9